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Abstract 
OBJECTIVES: To compare the mammographic densities and other characteristics of Aboriginal and 
non-Aboriginal women screened in Australia. METHODS: Population screening programme data of 
Aboriginal (n = 857) and non-Aboriginal women (n = 3236) were used. Mann-Whitney U test compared 
ages at screening and Chi-square tests compared personal and clinical information. Logistic regression 
analysis was used for density groupings. OR and 95% CI were calculated for multivariate association 
for density. RESULTS: Mammographic density was lower amongst Aboriginal women (P < 0.001). 
For non-Aboriginal women, higher density was associated with younger age (OR 2.4, 95% CI 2.1-2.8), 
recall to assessment (OR 2.2, 95% CI 1.6-3.0), family history of breast cancer (OR 1.4, 95% CI 1.2-
1.6), English-speaking background (OR 1.4, 95% CI 1.2-1.6), and residence in remote areas (OR 1.2, 
95% CI 1.1-1.4). For Aboriginal women, density was associated with younger age (OR 2.7, 95% CI 
2.0-3.5; P < 0.001), and recall to assessment (OR 2.3, 95% CI 1.4-3.9; P < 0.05). CONCLUSIONS: 
Significant differences between Aboriginal and non-Aboriginal women were found. There were more 
significant associations for dense breasts for non-Aboriginal women than for Aboriginal women. 
Keywords 
Aboriginal Australians; Mammographic density; Breast cancer 
Introduction 
Female breast cancer accounts for 25% of all cancers diagnosed in Aboriginal and Torres Strait Islander 
Australians, henceforth respectfully referred to as Aboriginal, with an estimated 1 in 11 Aboriginal 
women developing the disease [1, 2]. Although breast cancer incidence is lower by up to 20% for 
Aboriginal women compared with other Australians, Aboriginal women experience poorer prognoses 
with consistently lower survival rates and higher rates of death [3, 4]. The inequalities in outcomes are 
well documented and have been attributed to a combination of factors and disparities between 
Aboriginal and non-Aboriginal people. Evidence suggest that Aboriginal women are more likely than 
their non-Aboriginal counterparts to experience socio-economic disadvantage, present with co-
morbidities, live in more remote locations, are younger at diagnosis with more distant spread or 
advanced breast cancer, and are less likely to participate in breast screening [2, 4-8]. However, studies 
on risk factors for breast cancer specifically relevant to Aboriginal Australians are currently scarce, thus 
limiting cancer control strategies for this group of women in Australia.  
Breast density refers to the composition of fibroglandular and fat tissues in the breast and is well 
reported as having a strong direct relationship with breast cancer risk. Women with predominantly fatty 
or low dense breasts, regardless of the presence of other risk factors such as age, menopausal status, 
genetics, hormonal agents, and elements of lifestyle, confer a lower risk for breast cancer [9]. Moreover, 
breast density is also reported to affect mammographic sensitivity with evidence of highly dense breasts 
presenting challenges for radiologists in detecting invasive cancers [10]. Mammographic density can 
be measured by both qualitative and quantitative methods, via automated tools and manual means using 
area and volume percentages or specific classification techniques [11]. The Australian BreastScreen 
programme and the Royal Australian and New Zealand College of Radiologists have provided 
guidelines for the reporting of density in clinical practice using four categories similar to the American 
College of Radiology, Breast Imaging Reporting and Data System (BI-RADS) version 4 (2003) lexicon 
[12]. While Australian clinicians are encouraged by governing bodies to include density grades in 
clinical reports, there is currently no mandate to routinely provide women with information about breast 
density, nor routinely recommend supplemental imaging procedures for women with dense breasts. In 
the USA, at the time of writing this article, 32 states have passed legislation for women who have 
undergone mammography to be notified of breast density and their risks. 
Ethnic variations in breast density and associations with breast cancer risks have been shown in different 
populations around the world although reasons for variations remain unclear. Aleut and Native 
American women of Alaska reported lower mammographic density than Eskimo women [13], and 
African-American women had lower median per cent density compared with Asian-Americans [14]. 
Caucasian women in the UK had higher age-adjusted mean per cent density than South Asian, and Afro-
Caribbean women [15]. In New Zealand, Caucasian women were found to have lower volumetric 
density than Maori women but not lower than Pacific Islander women, and Asians had the highest 
measures amongst all women [16]. Evidence for the variation between the breast density measures of 
Aboriginal and non-Aboriginal Australians is yet to be demonstrated. The aim of the current work is to 
profile the mammographic densities of Aboriginal and non-Aboriginal women in the NT where up to 
30% of the population identifies as Aboriginal. Differences in the demographical and personal 
characteristics of Aboriginal and non-Aboriginal women will also be investigated and density covariates 
within populations of women will be explored.  
Methods 
Ethical approval was provided by the Human Research Ethics Committee (HREC) of the NT 
Department of Health and Menzies School of Health Research (HREC 2016-2627). The Aboriginal 
Health and Medical Research Council of New South Wales were informed of this study as the statistical 
analysis of data pertaining to Aboriginal Australians was conducted in New South Wales (NSW). 
Written consent to use information collected during breast screening was obtained from each participant 
at the time that they were screened.  
 
The study was performed retrospectively using a client data sample retrieved from BreastScreen NT, a 
population screening programme. The sample consisted of 4093 (857 self-reported as Aboriginal and 
3236 as non-Aboriginal) women aged between 40 and 85 years who were routinely screened between 
30 March and 24 November 2015. Breast mammograms were performed at permanent screening 
facilities in Darwin, Palmerston, and Alice Springs, and via the BreastScreen NT mobile bus units that 
service remote to very remote communities in the NT. Digital image files were sent electronically to 
Sydney Breast Clinic (SBC) in NSW, for radiologist interpretation. Each case was read by two 
radiologists who allocated a ‘Recall’ or ‘Normal’ finding and where two radiologists gave conflicting 
decisions (n = 302), a third radiologist acted as arbitrator. 
Radiologists at SBC used the American College of Radiology BI-RADS version 4 (2003) to allocate 
each case with a mammographic density score from 1 to 4. The density categories are defined as: 1 = 
almost entirely fatty, approximately 0–25% density; 2 = scattered areas of fibroglandular density, 
approximately 25–50% density; 3 = heterogeneously dense, approximately 50–75% density; and 4 = 
extremely dense, approximately 75–100% density. Density scores were given by either one or two 
radiologists at SBC at the time of screen reading. In instances where two radiologists’ density scores 
varied by more than 1 BI-RADS score (n = 24), a third reader was asked to arbitrate. In all other cases 
with density scores disagreement of only 1 BI-RADS score (n = 970), the middle score was used [17]. 
Women with breast implants (n = 46) were excluded from this study.  
Women’s personal details such as date of birth, residential and postal address, Aboriginal status, English 
speaking background (ESB) or non-English-speaking background (NESB), family history of breast 
cancer, previous breast cancer and year of diagnosis, current symptoms, and use of hormone 
replacement therapy (HRT) within the last 6 months, were extracted from the NT Department of Health 
computerised database. This information was obtained from the Personal Information and Consent 
forms that are routinely completed by clients prior to screening. Personal information was linked to 
clinical notes before the investigators of this study de-identified the data for analysis. 
Women’s residential addresses were categorised based on the Australian Statistical Geographical 
Standards Remoteness Areas classification (ASGSRA) [18]. In the NT, only three categories are 
available: outer regional, remote, and very remote. The capital city, Darwin, is classed as outer regional 
because it is not considered to be a provider of Category A services in education and health, nor does it 
have a population equal to or more than 250,000 persons.  
In the first stage of analysis, baseline differences between Aboriginal and non-Aboriginal women were 
explored. Due to the non-Gaussian nature of the data, the median age of women screening was analysed 
by Mann–Whitney U test. Categorical variables such as density groupings, HRT use, family history of 
breast cancer, current symptoms, previous breast cancer diagnosis, geographical remoteness, language 
background, and case outcome were analysed using Chi-square test.  
The second part of the analysis treated density as a dichotomous variable and compared women with 
dense breasts (BI-RADS 3 and 4) with those having fatty breast (BI-RADS 1 and 2) for all screened 
women, Aboriginal women only, and finally non-Aboriginal women only. The difference for age, a 
non-normally distributed continuous variable, was analysed using a Mann–Whitney U test, and 
categorical variables (geographical remoteness, language background, HRT use, family history of 
breast cancer, previous breast cancer diagnosis, symptoms and case outcome), were analysed using Chi-
square tests. ROC curve analysis was used to determine a cut-off point which best facilitated allocation 
of these variables into two groups: above and below cut-off points [19]. For example, the cut-off point 
for age which best separated women based on density was 55 years. Using this cut-off value, 
unconditional logistic regression was used to derive OR and 95% CIs. A P value was obtained from a 
two-tailed test, and a P value of\0.05 was considered significant. Multivariate logistic regression was 
performed on variables with univariate association of P B 0.2. Variables were retained in the model if 




Several significant differences were seen between the characteristic of Aboriginal and non-Aboriginal 
women, and these are summarised in Table 1. Aboriginal women were significantly younger than non-
Aboriginal women (p<0.001) with median ages of 54 years (IQR 48–60 years) and 57 years (IQR 52–
63 years), respectively. A lower proportion of Aboriginal women were living in outer regional areas 
compared with non-Aboriginal women with more Aboriginal women living in remote to very remote 
locations (p<0.001). English was the predominant language spoken by non-Aboriginal women and for 
Aboriginal women a larger proportion spoke Aboriginal languages (p<0.001). Mammographic density 
was lower amongst Aboriginal compared with non-Aboriginal women, while Aboriginal women were 
less likely to use HRT compared with non-Aboriginal women (p<0.001). Finally, Aboriginal women 
reported less family history of breast cancer compared with their non-Aboriginal counterparts. No other 
significant differences were shown for the characteristics, and full details are given in Table 1. 
  
Table 1. Characteristics of women by Aboriginal and non-Aboriginal statuses 
Variables Aboriginal N (%) Non-Aboriginal N (%) p value 
Age (y)       
Median (Q1, Q3) 54 (48,60) 57 (52,63)  <0.001ᵃ 
<55 481 (56.1%) 1399 (43.2%) 
 <0.001ᵇ 
≥55 376 (43.9%) 1837 (56.8%) 
Place of residence ᶜ       
Outer regional 118 (13.8%) 1823 (56.9%) 
 <0.001ᵇ Remote 579 (67.7%) 1172 (36.2%) 
Very remote 159 (18.6%) 209 (6.5%) 
English speaking background (ESB)       
ESB  245 (28.7%) 2721 (84.2%) 
 <0.001ᵇ 
Non-ESB 610 (71.3%) 511 (15.8%) 
non-English language type  
  
  
Aboriginal language  607 (99.5%) 7 (1.4%) 
 <0.001ᵇ 
Other language  3 (0.5%) 504 (98.6%) 
Mammographic density (BI-RADS)     
1 169 (19.7%) 424 (13.1%) 
 <0.001ᵇ 
2 353 (41.2%) 1207 (37.3%) 
3 240 (28%) 963 (29.8%) 
4 95 (11.1%) 642 (19.8%) 
Fatty breast (1,2) 522 (60.9%) 1631 (50.4%) 
 <0.001ᵇ 
Dense breast (3,4) 335 (39.1%) 1605 (49.6%) 
HRT use within 6 months  ͤ       
No 840 (98%) 2950 (91.4%) 
 <0.001ᵇ 
Yes 17 (2%) 278 (8.6%) 
Family history of breast cancer ᶠ       
No 613 (80.7%) 1961 (66.1%) 
 <0.001ᵇ 
Yes 147 (19.3%) 1007 (33.9%) 
1st degree relative ᵍ  61 (75.3%) 429 (67%) 
0.13ᵇ 
2nd degree relative ᵍ  20 (24.7%) 211 (33%) 
Previous breast cancer diagnosis       
No 485 (98.6%) 3161 (97.7%) 
0.09ᵇ 
Yes 12 (1.4%) 75 (2.3%) 
Current lump       
No  828 (96.6%) 3121 (96.4%) 
0.81ᵇ 
Yes 29 (3.4%) 115 (3.6%) 
Current nipple discharge       
No 851 (99.3%) 3215 (99.4%) 
0.86ᵇ 
Yes  6 (0.7%) 21 (0.6%) 
Case decision       
Normal 729 (92.4%) 3039 (93.9%) 
0.11ᵇ 
Recalled 65 (7.6%) 197 (6.1%) 
ᵃ Reported by a Mann-Whitney U test; ᵇ Reported by a Pearson Chi-square test; ᶜ Visitors (n=33) 
were excluded; ͩ Not known (n=6) was excluded; ͤ Not known (n=1) was excluded; ᶠ Not known 
(n=365) were excluded; ᵍ Not known (n=390) and paternal (n=43) were excluded 
Mammographic density in all women grouped together 
Univariate analysis was used to examine factors associated with density for all women, and the data are 
summarised in Table 2. Odds ratios were calculated to quantify the associations of variables to high 
density. A significant difference was evident between the mean ages of women with dense breasts (BI-
RADS 3 and 4) versus fatty breasts (BI-RADS 1 and 2), at 54.8 and 58.2 years, respectively (p<0.001). 
The ROC analysis determined an age cut-off of 55 years which best separated women based on density. 
Women below this threshold were 2.3 times more likely to have dense breasts compared with women 
above the cut-off (95% CI 2.0–2.6; p<0.001). Other significant associations with density that were 
observed were: non-Aboriginal women were 50% more likely to have dense breasts than Aboriginal 
women (OR 1.5, 95% CI 1.3–1.8;  p<0.001); individuals with a non-English-speaking background 
(NESB) that were not Aboriginal-language speakers were 70% more likely to have dense breasts than 
Aboriginal-language speakers (OR 1.7, 95% CI 1.3–2.1; p<0.001); participants with family histories of 
breast cancer were 40% more likely to have dense breasts compared with women who reported no 
family history of breast cancer (OR 1.4, 95% CI 1.2–1.6; p<0.001); individuals who reported having a 
breast lump were 50% more likely to have dense breasts compared with those who did not (OR 1.5, 
95% CI 1.1–2.2; p<0.05); and recalled women were 2.2 times more likely to have dense breasts than 
non-recalled cases (95% CI 1.7–2.8; p<0.001). No other significant differences were observed. The 
association of HRT use and density resulted in p=0.05 (OR 1.3, 95% CI 1.0–1.6; P 0.05), and this was 
retained in the model and tested for multivariate association in the next stage of analysis. 
  
Table 2 Association of density with other characteristics for all women 
Variables Fatty Breast N 
(%) 
Dense Breast N 
(%) 
p value OR (95% CI) 
Age (y)         
Median (Q1, Q3) 54 (48,60) 57 (52,63)  <0.001ᵃ   
≥55 1451 (61.3%) 915 (38.7%) 
 <0.001ᵇ 2.3 (2.0-2.6) 
<55 702 (40.6%) 1025 (59.4%) 
Aboriginal status         
Aboriginal 522 (60.9%) 335 (39.1%) 
 <0.001ᵇ 1.5 (1.3-1.8) 
Non-Aboriginal 1631 (50.4%) 1605 (49.6%) 
Place of residence         
Outer regional 1040 (53.3%) 912 (46.7%) 
0.44ᵇ 1.0 (0.9-1.2) 
Remote and very remote 1104 (52.1%) 1016 (47.9%) 
English speaking background (ESB)         
Non-ESB 604 (53.9%) 517 (46.1%) 
0.31ᵇ 1.1 (0.9-1.2) 
ESB 1545 (52.1%) 1421 (47.9%) 
non-English language type  
  
   
Aboriginal language  367 (59.8%) 247 (40.2%) 
 <0.001ᵇ 1.7 (1.3-2.1) 
Other language  237 (46.7%) 270 (53.3%) 
HRT use within 6 months         
No 2014 (53%) 1783 (47%) 
0.05ᵇ 1.3 (1.0-1.6) 
Yes 139 (47.1%) 156 (52.9%) 
Family history of breast cancer         
No 1412 (54.9%) 1162 (45.1%) 
 <0.001ᵇ 1.4 (1.2-1.6) 
Yes 544 (47.2%) 610 (52.9%) 
1st degree relative ᶜ 228 (46.5%) 262 (53.5%) 
0.36ᵇ 1.2 (0.9-1.6) 
2nd degree relative ᶜ 99 (42.9%) 132 (57.1%) 
Previous breast cancer diagnosis         
Yes 50 (57.5%) 37 (42.5%) 
0.36ᵇ 1.2 (0.8-1.9) 
No 2103 (52.8%) 1903 (47.2%) 
Current lump         
No 2092 (53%) 1857 (47%) 
 <0.05ᵇ 1.5 (1.1-2.2) 
Yes 61 (42.4%) 83 (57.6%) 
Current nipple discharge         
No 2141 (52.7%) 1925 (47.3%) 
0.39ᵇ 1.4 (0.6-3.0) 
Yes 12 (44.4%) 15 (55.6%) 
Case decision         
Normal 2062 (53.8%) 1769 (46.2%) 
 <0.001ᵇ 2.2 (1.7-2.8) 
Recalled 91 (34.7%) 171 (65.3%) 
ᵃ Reported by Mann-Whitney U test; ᵇ Reported by a Pearson Chi-square test; ᶜ Not known (n=390) 
and paternal (n=43) were excluded. Note: The reference groups for ORs are always presented in the 
first row of the variables. 
Using the significant variables in Table 2, multivariate stepwise logistic regression analysis 
demonstrated that the significant predictors for dense breasts for all women were family history of 
breast cancer (OR 1.3, 95% CI 1.1–1.5; p<0.001), non-Aboriginal status (OR 1.7, 95% CI 1.4–2.0; 
p<0.001), recalled case (OR 2.3, 95% CI 1.7–3.0; p<0.001), and being under 55 years of age (OR 2.5, 
95% CI 2.1–2.8; p<0.001) (Figure 1). 
able 
Figure 1. Factors associated with high mammographic density (BI-RADS 3 and 4) for all women 
screened in the NT in 2015. 
Mammographic density of women allocated to Aboriginal or non-Aboriginal groups 
The second part of this study evaluated factors associated with density within Aboriginal women and 
non-Aboriginal women separately. Full details are shown in Table 3. Amongst Aboriginal women, the 
characteristics that are significantly associated with density were age, with women younger than 55 
years 2.7 times more likely to have dense breasts than older women (95% CI 2.0–3.5; p<0.001), and 
case decision, with recalled women 2.3 times more likely to have dense breasts compared with women 
whose cases were considered normal (95% CI 1.4–3.9; p<0.05). For non-Aboriginal women, the 
characteristics that are significantly associated with density are younger age (OR 2.4, 95% CI 2.1–2.8; 
p<0.001), residence in remote locations (OR 1.2, 95% CI 1.1–1.4; p<0.05), English speaking 
background (ESB) (OR 1.4, 95% CI 1.2–2.6; p<0.05); family history of breast cancer (OR 1.4, 95% CI 
1.2–1.6; p<0.001), current lump (OR 1.5, 95% CI 1.0–2.2; p<0.05), and recalled case (OR 2.2, 95% CI 
1.6–3.0; p<0.001). 














N (%) p valueᵃ  OR (95% CI) 
Age (y)                   
≥ 55 291 (72.9%) 108 (27.1%) 
 <0.001 
1.0 (Ref)   1160 (59%) 807 (41%) 
<0.001 
1.0 (Ref) 
< 55 231 (50.4%) 227 (49.6%) 2.7 (2.0-3.5)   471 (37.1%) 798 (62.9%) 2.4 (2.1-2.8) 
Place of residence                   
Outer regional 77 (64.7%) 42 (35.3%) 
0.36 1.2 (0.8-1.9) 
 
963 (52.5%) 870 (47.5%) 
<0.05 1.2 (1.1-1.4) Remote to very remote 445 (60.3%) 293 (39.7%) 
 
659 (47.7%) 723 (52.3%) 
English speaking background (ESB)                   
ESB 154 (62.9%) 91 (37.1%) 
0.49 1.1 (0.8-1.5) 
 
236 (46.2%) 275 (53.8%) 
<0.05 1.4 (1.2-1.6) Non-ESB 368 (60.3%) 242 (39.7%) 
 
1391 (51.1%) 1330 (48.9%) 
non-English language type 
        
  
Other language 2 (66.7%) 1 (33.3%) 
0.82 1.3 (0.1-14.7) 
 
235 (46.6%) 269 (53.4%) 
0.09 5.2 (0.6-43.5) Aboriginal language  366 (60.3%) 241 (39.7%) 
 
1 (14.3%) 6 (85.7%) 
HRT use within 6 months                   
No 511 (60.8%) 329 (39.2%) 
0.75 0.9 (0.3-2.3) 
 
1503 (50.8%) 1454 (49.2%) 
0.13 1.2 (1.0-1.6) Yes 11 (64.7%) 6 (35.3%) 
 
128 (46%) 150 (54%) 
Family history of breast cancer                   
No 369 (60.2%) 244 (39.8%) 
0.82 1.0 (0.7-1.5) 
 
1043 (53.2%) 918 (46.8%) 
<0.001 1.4 (1.2-1.6) Yes 87 (59.2%) 60 (40.8%) 
 
457 (45.4%) 550 (54.6%) 
1st degree relative 37 (60.7%) 24 (39.3%) 
0.40 1.5 (0.6-4.3) 
 
191 (44.5%) 238 (55.5%) 
0.57 1.1 (0.8-1.5) 2nd degree relative 10 (50%) 10 (50%) 
 
89 (42.2%) 122 (57.8%) 
Previous breast cancer diagnosis                 
Yes 8 (66.7%) 4 (33.3%) 
0.68 1.3 (0.4-4.3) 
 
1589 (53.3%) 1572 (49.7%) 
0.33 1.3 (0.8-2.0) No 514 (60.8%) 331 (39.2%) 
 
42 (56%) 33 (44%) 
Current lump                   
No 508 (61.4%) 320 (38.6%) 
0.16 1.7 (0.8-3.6) 
 
1584 (50.8%) 1587 (49.2%) 
<0.05 1.5 (1.0-2.2) Yes 14 (48.3%) 15 (51.7%) 
 
47 (40.9%) 68 (59.1%) 
Current nipple discharge                   
No 519 (61%) 332 (39%) 
0.58 1.6 (0.3-7.8) 
 
1622 (50.5%) 1593 (49.5%) 
0.49 1.4 (0.6-3.2) Yes 3 (50%) 3 (50%) 
 
9 (42.9%) 12 (57.1%) 
Case decision                   
Normal 495 (62.5%) 297 (37.5%) 
<0.01 2.3 (1.4-3.9) 
 
1567 (51.6%) 1472 (48.4%) 
<0.001 2.2 (1.6-3.0) Recalled 27 (41.5%) 38 (58.5%)   64 (32.5%) 133 (67.5%) 
ᵃ Reported by a Pearson Chi-square test. Note: The reference groups for ORs are always presented in the first row of each variable 
Using the significant variables in Table 3, multivariate stepwise logistic regression analysis 
demonstrated the characteristics most strongly associated with density in groups of women separately 
(Figure 2). For Aboriginal women, density was associated with younger age (OR 2.7, 95% CI 2.0–3.5) 
and case decision (OR 2.3, 95% CI 1.4–3.9). For non-Aboriginal women, density was associated with 
younger age (OR 2.4, 95% CI 2.1–2.8), recalled case (OR 2.2, 95% CI 1.6–3.0), family history of breast 
cancer (OR 1.4, 95% CI 1.2–1.6), English-speaking background (ESB) (OR 1.4, 95% CI 1.2–1.6), and 
residence in remote areas (OR 1.2, 95% CI 1.1–1.4).  
 
Figure 2.Factors associated with high mammographic density (BI-RADS 3 and 4) for Aboriginal and 
non-Aboriginal women screened in the NT of Australia in 2015.  
Key: ESB refers to English-speaking background 
Discussion 
These findings describe the characteristics of the breast screening population in the NT of Australia. 
Prior to this study, evidence of variations between the BI-RADS mammographic densities of Aboriginal 
and non-Aboriginal women from an Australian screening population was unavailable. The current work 
highlights the differences between Aboriginal and non-Aboriginal women and identifies the factors 
strongly associated with mammographic density. Consistent with national population statistics and 
evidence from previous studies in the screening population [4, 20, 21], this study found that Aboriginal 
women were younger at screening than their non- Aboriginal counterparts with 12.9% fewer Aboriginal 
women over 55 years. Even so, average mammographic density was significantly lower amongst 
Aboriginal women compared with non-Aboriginal women. This finding is congruent with a previous 
study that used the Tabar method to classify mammographic parenchymal pattern and showed that 
Aboriginal women in a NSW screening programme had predominantly fatty breasts [22]. Our study, 
however, is the first, to our knowledge, to report density profiles of Aboriginal Australians using the 
widely employed BI-RADS version 4 (2003) approach. 
Younger age was the strongest covariate for mammographic density for both Aboriginal and non-
Aboriginal women. This finding is aligned with the well-established inverse relationship between age 
and density [23]. Internationally, evidence in USA [13, 14], UK [15], Asia [24, 25], and New Zealand 
[16] report variations in densities between ethnic groups and the reasons for these differences remain 
unclear. A recent study that examined breast density across 40 ethnicities and location-specific 
populations in 22 countries found that common to all women and regardless of ethnicity, the 
menopausal status of any age had the strongest association with breast density [26]. While this current 
work is limited by the absence of women’s menopausal statuses, other variables were found to be 
strongly associated with density.  
Cases that were recalled for further tests were more likely to be mammographically dense than those 
that were not, and this was strongly associated with density for all women. One explanation is that dense 
breasts are more complex to interpret, and it is more difficult to be confident that the appearances are 
normal, hence yielding higher recall rates. Another explanation could be the well-established positive 
association between mammographic density and breast cancer risk that radiologists are likely attuned 
to. This awareness of risk was demonstrated by the study by Al Mousa and colleagues that used eye-
tracking analysis and found that the performance of expert radiologists improved for cases with 
increased mammographic density [27, 28]. It demonstrated that density presents an important visual 
cue signifying higher risk. While our findings cannot comment on cancer detection rates in the absence 
of pathology data, the tendency to recall dense breasts in this sample underscores the radiologists’ 
perceived increased breast cancer risk in these cases. 
Previous studies have shown that women with higher breast density were more likely to have relatives 
with past or present breast cancers compared with women with lower breast density [29, 30]. Our 
finding supports this with both lower density and fewer family histories of breast cancer reported for 
Aboriginal women. We also found that breast cancer in the family had significant multivariate 
association for non-Aboriginal women but not for Aboriginal women. This is unsurprising given the 
lower breast cancer incidence and lower rates of breast screening attendance in the Aboriginal 
population compared with the general population. Therefore, reports of family history of the disease are 
expected to be lower in the Aboriginal population. 
The relationship between remoteness and density was only significant for non-Aboriginal women but 
not for Aboriginal women and it was not significant for all women grouped together. Non-Aboriginal 
women who were remotely located showed higher density than non-Aboriginal women living in outer 
regional areas. Consistent with national population data [20], there were more Aboriginal women living 
in remote to very remote locations compared with non-Aboriginal women in our sample. The higher 
fertility rate of remote-living Aboriginal women compared with Aboriginal women living in urban and 
regional areas [31], the younger age profile and the breastfeeding practices of Aboriginal mothers in 
general [32, 33] could potentially explain this result since parity, younger age at first birth, and 
breastfeeding have well-established associations with low density [34, 35]. Also, women living in 
Aboriginal communities which are mainly located in very remote regions of Australia would be less 
exposed to a range of other Westernised lifestyle factors that may have health impacts [36, 37]. 
Most non-Aboriginal women reported speaking predominantly English at home while most Aboriginal 
women mainly spoke Aboriginal languages. This is possibly linked with the prevalence of Aboriginal 
women living in remote to very remote locations where traditional languages are more likely to be 
spoken. According to census data [20], 15% of the general NT population speak Aboriginal languages 
and our result is a good representation of this with 15% of the women in our sample speaking Aboriginal 
languages. With regard to density, non-Aboriginal women with English-speaking background (ESB) 
showed stronger association with density than non-Aboriginal NESB women; however, when all 
women are considered, the variation in densities by ESB or NESB status was not significant. When all 
NESB women were further classified into either ‘Aboriginal language’ speakers or ‘other non-English’ 
speakers, the latter group showed higher probability of dense breasts compared with the former. Simply 
put, non-Aboriginal women who are not native English language speakers had higher density than their 
Aboriginal counterparts. In the NT, 19% of the population was born overseas and 15% speak in their 
native languages. While ethnicity and language use has been previously reported as an important 
determinant of density [24, 38], our results suggest that within NESB women, there is heterogeneity in 
terms of density and therefore stratifying women based on language and ethnic origin rather than 
considering them as a single non-English-speaking unit should be the focus of further work. 
The association between HRT use and breast density is well-established [29, 39]. However, studies into 
the menopausal status and HRT use of Aboriginal women are globally scarce. While this study did not 
collect information on the menopausal statuses and types of HRT, our findings contribute to the 
currently limited knowledge of HRT use amongst Aboriginal Australians as compared with the non-
Aboriginal population. Aboriginal women in our sample had a significantly lower rate of HRT use than 
non-Aboriginal women and the reasons for this could be similar to those reported in previous studies, 
those being, fear of using medication, an inclination towards coping with menopause symptoms 
naturally [40] and limited understanding of menopause, its symptoms and treatment options [41]. With 
regard to HRT use and density, univariate analyses found no significant associations for Aboriginal and 
non-Aboriginal women separately. 
One of the disadvantages of a retrospective study such as this one is that some key variables cannot be 
measured because data were either not available or not routinely collected. While pathology data for 
this sample would be useful in showing how differences in density measures between groups of women 
in the NT relate to cancer detection and cancer risk, it must be noted that NT has the lowest breast 
cancer incidence in Australia (88 per 100,000 women vs. 115 per 100,000 nationwide) and invasive 
breast cancers in the Australian screening population is observed in 1 in every 200 cases [3]. Therefore, 
our sample (n = 4093) would potentially only yield a small number of cancer cases with low statistical 
power. To overcome this, further study using a larger sample size with high prevalence is warranted. 
In addition to the absence of pathology data, menopausal status, and types of HRT as described above, 
a further limitation of this study is the lack of information on the body mass index (BMI) of individual 
women. As with age, body size is a critical predictor of breast density therefore adjustment for age and 
BMI is necessary [42]. Indeed, studies in the USA found that differences in breast densities across racial 
groups were significant when controlling for age and BMI [43, 44]. This critical variable could therefore 
impact the finding in this current work with the possibility of rendering significant associations null. 
With the reported difference between the body sizes of Aboriginal and non-Aboriginal women, in that 
Aboriginal women are 1.7 times more likely to have BMI >30.00 compared with non-Aboriginal 
women [5], we may have expected to see high BMI associated with increased non-dense area in the 
breast for Aboriginal women. 
Furthermore, the absence of information regarding the reproductive histories of women and certain 
behaviours that have inverse associations with breast density such as smoking and physical activity 
limit the scope of this work These factors are particularly important since Aboriginal women are 
reported to be twice as likely as non-Aboriginal women to have a daily smoking habit with the highest 
rates in remote areas, have higher rates of fertility, and lower rates of physical activity [32]. Processes 
which enable a more comprehensive gathering of data related to breast density and breast cancer would 
facilitate greater epidemiological yield and should be explored. 
Conclusion 
This work has shown that for Aboriginal and non-Aboriginal women, younger age and being recalled 
to screening were strongly associated with density; however, for non- Aboriginal women, the following 
were additional covariates: HRT use, family history of breast cancer, remote residence, and language. 
We also reported significant differences in age profiles, geographical distribution, languages, HRT, and 
family histories of the disease between Aboriginal and non-Aboriginal women in the NT. This work 
contributes to the sparse literature on Aboriginal women in the BreastScreen NT population. With 
concomitant lower screening participation, younger age at diagnosis, and higher rates of death from 
breast cancer in Aboriginal women compared with non-Aboriginal women, a further key area of future 
study will be to explore if the differences in breast density are related to ethnic differences in breast 
cancer risk. 
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